Overview

A Study to Evaluate Potential Drug Interactions Between ALXN2080 and Itraconazole, Fluconazole & Carbamazepine in Healthy Adults

Status:
Recruiting

Trial end date:
2024-05-06

Target enrollment:

Participant gender:

Summary

The primary objectives of this study are to determine the effect of multiple doses of itraconazole on the single dose PK of ALXN2080, to determine the effect of multiple doses of fluconazole on the single dose PK of ALXN2080 (optional), and to determine the effect of multiple doses of carbamazepine on the single dose PK of ALXN2080.

Phase:

Phase 1

Details

Lead Sponsor:

Alexion Pharmaceuticals, Inc.

Treatments:

Carbamazepine
Fluconazole
Itraconazole